Artra Group Corporation (6029.T)
JPY 134.0
(-2.19%)
JPY 134.0
(-2.19%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 228.12 Million JPY | 17.83% |
| 2022 | 190.55 Million JPY | 362.06% |
| 2021 | -163.54 Million JPY | 72.06% |
| 2020 | -226.69 Million JPY | -227.04% |
| 2019 | 77.48 Million JPY | -42.73% |
| 2018 | 727.87 Million JPY | -45.84% |
| 2017 | 555.6 Million JPY | 49.93% |
| 2016 | 322.3 Million JPY | -25.94% |
| 2015 | 502.84 Million JPY | 386.37% |
| 2014 | 104.03 Million JPY | -42.78% |
| 2013 | 182.42 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 9.48 Million JPY | -94.44% |
| 2024 Q2 | 12.67 Million JPY | 73.67% |
| 2023 Q2 | 6.56 Million JPY | 110.42% |
| 2023 Q4 | 142.78 Million JPY | 850.53% |
| 2023 Q1 | -63.05 Million JPY | -1519.09% |
| 2023 FY | - JPY | 18.04% |
| 2023 Q3 | 15.02 Million JPY | 128.75% |
| 2022 Q3 | 24.72 Million JPY | 159.08% |
| 2022 Q2 | 9.54 Million JPY | 140.41% |
| 2022 FY | - JPY | 362.06% |
| 2022 Q1 | -23.61 Million JPY | 71.49% |
| 2022 Q4 | 4.44 Million JPY | -82.03% |
| 2021 Q4 | -82.82 Million JPY | 19.89% |
| 2021 FY | - JPY | 72.06% |
| 2021 Q2 | 24.73 Million JPY | 143.29% |
| 2021 Q3 | -103.39 Million JPY | -518.04% |
| 2021 Q1 | -57.12 Million JPY | 78.26% |
| 2020 FY | - JPY | -227.04% |
| 2020 Q1 | -75.24 Million JPY | -543.41% |
| 2020 Q4 | -262.8 Million JPY | -746.33% |
| 2020 Q3 | -31.05 Million JPY | -5.43% |
| 2020 Q2 | -29.45 Million JPY | 60.86% |
| 2019 FY | - JPY | -42.73% |
| 2019 Q4 | 16.96 Million JPY | 234.69% |
| 2019 Q1 | 24.89 Million JPY | 145.77% |
| 2019 Q2 | 9.38 Million JPY | -62.31% |
| 2019 Q3 | -12.59 Million JPY | -234.26% |
| 2018 Q2 | 122.75 Million JPY | 10.18% |
| 2018 Q1 | 111.4 Million JPY | -48.44% |
| 2018 Q4 | -54.39 Million JPY | -1113.47% |
| 2018 Q3 | 5.36 Million JPY | -95.63% |
| 2018 FY | - JPY | -45.84% |
| 2017 Q3 | 97.21 Million JPY | 8.56% |
| 2017 Q1 | 51.44 Million JPY | -44.0% |
| 2017 FY | - JPY | 49.93% |
| 2017 Q4 | 216.08 Million JPY | 122.27% |
| 2017 Q2 | 89.54 Million JPY | 74.06% |
| 2016 Q1 | 87.46 Million JPY | -69.31% |
| 2016 Q3 | 41.44 Million JPY | 32.8% |
| 2016 Q2 | 31.2 Million JPY | -64.32% |
| 2016 Q4 | 91.87 Million JPY | 121.69% |
| 2016 FY | - JPY | -25.94% |
| 2015 FY | - JPY | 386.37% |
| 2015 Q2 | 91.1 Million JPY | 561.26% |
| 2015 Q1 | 13.77 Million JPY | -19.01% |
| 2015 Q4 | 284.94 Million JPY | 326.91% |
| 2015 Q3 | 66.74 Million JPY | -26.74% |
| 2014 FY | - JPY | -42.78% |
| 2014 Q4 | 17.01 Million JPY | 0.0% |
| 2013 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AS PARTNERS CO LTD | 1.07 Billion JPY | 78.874% |
| I'rom Group Co., Ltd. | 2.27 Billion JPY | 89.955% |
| Saint-Care Holding Corporation | 4.04 Billion JPY | 94.358% |
| UCHIYAMA HOLDINGS Co.,Ltd. | 1.23 Billion JPY | 81.524% |
| Charm Care Corporation | 6.31 Billion JPY | 96.385% |
| Elan Corporation | 3.85 Billion JPY | 94.079% |
| Solasto Corporation | 8.85 Billion JPY | 97.424% |
| teno. Holdings Company Limited | 616 Million JPY | 62.967% |
| Japan Hospice Holdings Inc. | 1.69 Billion JPY | 86.545% |
| baby calendar Inc. | 11.62 Million JPY | -1862.5% |
| Advantage Risk Management Co., Ltd. | 1.41 Billion JPY | 83.847% |